Review article · 2011

A point of minimal important difference (MID): a critique of terminology and methods

Madeleine Trudy King

Expert Review of Pharmacoeconomics & Outcomes Research, 11(2), 171–184 · Published 1 April 2011 · DOI 10.1586/erp.11.9

View at the publisherCite this paper

In brief

“A point of minimal important difference (MID): a critique of terminology and methods” is a 2011 review article by Madeleine Trudy King, published in Expert Review of Pharmacoeconomics & Outcomes Research. OpenAlex counts 702 citations as of 22 November 2026, which puts it in the top 1% of works published in 2011 by citations. The publisher's version is not open access, and OpenAlex records no free legal copy.

Citations
702
Most cited in
2021 (81)
Field-weighted impact
5.42
References
68
Authors
1

Abstract

The minimal important difference (MID) is a phrase with instant appeal in a field struggling to interpret health-related quality of life and other patient-reported outcomes. The terminology can be confusing, with several terms differing only slightly in definition (e.g., minimal clinically important difference, clinically important difference, minimally detectable difference, the subjectively significant difference), and others… Read the full abstract at the publisher.

Excerpt. This paper is not open access.

Cite this paper

Formatted from the catalogue record. Check names, capitals and page numbers against the paper before you submit.

APA 7

King, M. T. (2011). A point of minimal important difference (MID): a critique of terminology and methods. Expert Review of Pharmacoeconomics & Outcomes Research, 11(2), 171–184. https://doi.org/10.1586/erp.11.9

MLA 9

King, Madeleine Trudy. “A point of minimal important difference (MID): a critique of terminology and methods.” Expert Review of Pharmacoeconomics & Outcomes Research, vol. 11, no. 2, 2011, pp. 171–184. https://doi.org/10.1586/erp.11.9.

Chicago

King, Madeleine Trudy. 2011. “A point of minimal important difference (MID): a critique of terminology and methods.” Expert Review of Pharmacoeconomics & Outcomes Research 11 (2): 171–184. https://doi.org/10.1586/erp.11.9.

Harvard

King, M. T. (2011) ‘A point of minimal important difference (MID): a critique of terminology and methods’, Expert Review of Pharmacoeconomics & Outcomes Research, 11(2), pp. 171–184. doi:10.1586/erp.11.9.

IEEE

M. T. King, “A point of minimal important difference (MID): a critique of terminology and methods,” Expert Review of Pharmacoeconomics & Outcomes Research, vol. 11, no. 2, pp. 171–184, 2011, doi: 10.1586/erp.11.9.

BibTeX

@article{king2011point,
  title     = {{A point of minimal important difference (MID): a critique of terminology and methods}},
  author    = {King, Madeleine Trudy},
  journal   = {Expert Review of Pharmacoeconomics \& Outcomes Research},
  year      = {2011},
  volume    = {11},
  number    = {2},
  pages     = {171--184},
  doi       = {10.1586/erp.11.9},
  url       = {https://doi.org/10.1586/erp.11.9}
}

Download for a reference manager: BibTeX (.bib) · RIS for Zotero, Mendeley and EndNote (.ris)

Citations by year

YearCitationsShare of the best year
20174040
20185252
20195252
20206464
20218181
20226262
20235151
20246767
20256262
20264848

Its field-weighted citation impact is 5.42: it has been cited 5.42 times as often as the average work of the same field, type and year (1.00 is the world average).

Topic and keywords

Social Sciences › Economics, Econometrics and Finance › Economics and Econometrics › Health Systems, Economic Evaluations, Quality of Life

  • minimal important difference
  • patient-reported outcomes
  • health-related quality of life
  • terminology
  • standard error of measurement
  • effect size
  • minimal detectable change

Work with this paper

Most-cited papers in Economics, Econometrics and Finance

All highly cited Economics, Econometrics and Finance papers

Questions about this paper

How do I cite this paper in APA style?

King, M. T. (2011). A point of minimal important difference (MID): a critique of terminology and methods. Expert Review of Pharmacoeconomics & Outcomes Research, 11(2), 171–184. https://doi.org/10.1586/erp.11.9

How many times has this paper been cited?

702 times, according to OpenAlex on 22 November 2026. Google Scholar and Scopus count different sets of sources, so their numbers differ.

Is this paper free to read?

OpenAlex records no free legal copy. Check your library's access, the authors' pages or a repository, or ask the corresponding author for a copy.

Who wrote this paper?

Madeleine Trudy King.

What is the DOI of this paper?

10.1586/erp.11.9, permanently at https://doi.org/10.1586/erp.11.9. Sign in and open it from this page.

Bibliographic data from OpenAlex (CC0), last checked 22 November 2026. ResearchGuru does not host this paper; once you are signed in, the links open it at the publisher or the repository that does.